Sensex
79,809.65 profit arw -270.92 (-0.34%)
Nifty
24,426.85 profit arw -74.05 (-0.30%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 12-Aug-2025
Hot Pursuit
12-Aug-2025     13:50

Abbott India rises as Q1 PAT jumps 12% YoY to Rs 366 cr

Profit before tax (PBT) stood at Rs 493.13 crore in Q1 FY26, up 12.78% year on year (YoY).

Total expenses increased 10.97% to Rs 1,318.06 crore in Q1 FY26 as against Rs 1,187.72 crore posted in same quarter last year. The cost of materials consumed stood at Rs 146.18 crore (down 0.06% YoY), employee benefit expense was at Rs 168.01 crore (up 4.31% YoY) and finance cost was at Rs 5.82 crore (up 111.63% YoY) during the period under review.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

79,809.65 -270.92 (-0.34%)

Nifty

24,426.85 -74.05 (-0.30%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,077.63 78.80(0.32%)